Indeed, HLA-DRB1*13 alleles have been noted to affect the ACPA status, conferring protection for ACPA-positive RA and, in combination with HLA-DRB1*03, reducing the risk of ACPA-negative RA (53). This evidence concerns the gene PRTN3 and rheumatoid arthritis.